The core of Genefill is defined by Advanced Thixotropic Technology (ATT), which determines how gel molecules behave during and after injection to ensure a smooth application and high stability.
Thanks to a special manufacturing process, thixotropic molecules in Genefill gel have the ability to become less viscous under injection pressure. This process provides highly stable cross-linked HA molecules, allowing injection with reduced force and thinner needles, minimizing pain and ensuring optimal treatment comfort.
Hyaluronic acid molecules in conventional gels tend to permanently break down under injection pressure, which negatively impacts the duration and efficacy of fillers in the dermis. Molecules with enhanced thixotropic behavior in Genefill gels return to their original viscosity once pressure is released, resulting in a long-lasting and stable effect.
Certifications
Safety
Experience
Results
BioScience GmbH is a German manufacturer designing and producing medical devices based on hyaluronic acid.
As of today, we are one of the few manufacturers to offer both monophasic and biphasic dermal fillers.
We are committed to helping people maintain a youthful appearance and improve their overall quality of life.
Our knowledge and experience have earned us the trust of leading plastic surgeons and dermatologists worldwide.
